Nantahala Capital Management, LLC Milestone Pharmaceuticals Inc. Transaction History
Nantahala Capital Management, LLC
- $1.99 Billion
- Q4 2024
A detailed history of Nantahala Capital Management, LLC transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 1,445,264 shares of MIST stock, worth $2.36 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
1,445,264
Previous 1,750,000
17.41%
Holding current value
$2.36 Million
Previous $2.66 Million
28.2%
% of portfolio
0.17%
Previous 0.16%
Shares
2 transactions
Others Institutions Holding MIST
# of Institutions
51Shares Held
25.1MCall Options Held
61.2KPut Options Held
38.8K-
Black Rock Inc. New York, NY4.97MShares$8.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.7MShares$4.41 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.66MShares$4.33 Million2.16% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$4.08 Million0.1% of portfolio
-
Orbimed Advisors LLC San Diego, CA2MShares$3.26 Million0.13% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $48.9M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...